IMMUNDEFIZIENTE NAGER

European patent · EP3950949 · In force

Register entry

Publication number
EP3950949
Application number
EP20776454
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 26, 2020
Published
Feb 9, 2022
Granted
Dec 4, 2024
Protection ends at the latest
Mar 25, 2040
Next annual fee due
Mar 31, 2027
IPC classes
C12N 15/877 (2010.01)
A01K 67/027 (2024.01)
C12N 5/0789 (2010.01)
C12N 15/24 (2006.01)
C12N 15/27 (2006.01)
Priority
JP 2019062919 28.03.2019
PCT application
PCT/JP2020/013635 26.03.2020
PCT publication
WO2020/196742 01.10.2020
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Oct 15, 2025

    Change

    Published in Swissreg on 15.10.2025

  3. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  4. Dec 4, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.12.2024

Parties

Holder

Central Institute for Experimental Medicine and Life Science

3-25-12, Tonomachi Kawasaki-ku, Kawasaki-shi, Kanagawa 210-0821, JP

Inventor

ITO, Ryoji

Kawasaki-shi, Kanagawa 210-0821, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.